DCM Shriram Fine Chemicals Limited (NSE:DSFCL)

Market Cap	2.04B
Revenue (ttm)	3.83B -10.9%
Net Income	-35.20M
EPS	-0.41
Shares Out	86.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.40 (1.71%)
Ex-Dividend Date	n/a

Volume	41,352
Open	23.52
Previous Close	23.52
Day's Range	23.06 - 23.52
52-Week Range	17.28 - 52.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About NSE:DSFCL

DCM Shriram Fine Chemicals Limited engages in producing, contract manufacturing, and selling of chemicals and their by-products. Its Pharma products includes D (-) alpha phenyl glycine base, D (-) alpha phenyl glycine ethyl potassium dane salt, D (-) alpha phenyl glycine chloride hydrochloride, D (-) para hydroxy phenyl glycine base, D (-) para hydroxy phenyl glycine methyl potassium dane salt, D (-) para hydroxy phenyl glycine methyl ester, DL 2-(2-Chloro Phenyl) glycine, valine hydantoin, sodium phenoxy acetate, phenoxy acetic acid, phenyl ac...

• Industry: Chemicals and Allied Products
• Founded: 2021
• Employees: 529
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: DSFCL

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 18, 2026

Data Sources Report a data error